Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
46.28
+1.14 (+2.54%)
Streaming Delayed Price
Updated: 3:22 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi - American Depositary Shares
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
41
42
Next >
FDA Accepts Regeneron, Sanofi's Filing For Review In Skin Disease
↗
May 31, 2022
The U.S.
Via
Benzinga
Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike
May 31, 2022
Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood...
Via
FinancialNewsMedia
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
↗
May 22, 2022
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Via
Benzinga
Why Kymera Therapeutics Shares Are Falling Today
↗
May 03, 2022
Via
Benzinga
Dupixent, Consumer Healthcare Lifts Sanofi's Q1 Earnings, Backs FY22 Guidance
↗
April 28, 2022
Via
Benzinga
Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again
↗
April 28, 2022
Dupixent sales rocketed higher in the quarter, driven by continued uptake in eczema treatment.
Via
Investor's Business Daily
FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule
↗
May 20, 2022
The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc.
Via
Benzinga
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
↗
May 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Penny Stocks With 10x Potential This Year
↗
May 17, 2022
These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward.
Via
InvestorPlace
Sanofi To Pay €400K As Compensation For Epilepsy Drug-Related Side Effects
↗
May 16, 2022
A French court has ordered Sanofi SA (NASDAQ: SNY) to pay more than €400,000 in damages to a French family whose child had autism caused by its epilepsy drug Valproate.
Via
Benzinga
Sanofi Says Sarclisa Shows 'Unprecedented Median Progression-Free Survival' In Multiple Myeloma Patients
↗
May 16, 2022
Via
Benzinga
Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices
↗
May 13, 2022
Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit...
Via
Benzinga
Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now
↗
May 13, 2022
The race is on in eczema treatment as the biggest name faces new rivals.
Via
Investor's Business Daily
Psychedelic Medicine: The New Frontier In Healthcare, The Big Opportunity In Biopharma
↗
May 13, 2022
The story around psychedelic medicine continues to get bigger.
Via
Talk Markets
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY)
↗
May 11, 2022
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space...
Via
Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
↗
May 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
↗
May 11, 2022
Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV).
Via
Benzinga
Heart Failure Treatment Offers Hope to Diabetics
May 11, 2022
Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart...
Via
FinancialNewsMedia
7 Biotech Stocks With Key Catalysts for May
↗
May 11, 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
Via
InvestorPlace
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
↗
April 29, 2022
The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings.
Via
Investor's Business Daily
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
↗
April 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For April 28, 2022
↗
April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion.
Via
Benzinga
Microsoft Gives Glimpse Of Xbox Cloud Gaming Numbers
↗
April 27, 2022
Microsoft Corporation (NASDAQ: MSFT) CEO Satya Nadella said Tuesday that more than 10 million people have streamed games on its Xbox Cloud Gaming platform. What Happened: Nadella...
Via
Benzinga
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
↗
April 26, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a...
Via
Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
↗
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran
↗
April 25, 2022
Terran Biosciences is slowly but surely finding its place in the psychedelics industry.
Via
Benzinga
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
↗
April 22, 2022
Via
Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
↗
April 20, 2022
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.
Via
InvestorPlace
How To Attend Sanofi Q1 2022 Earnings Conference Call
↗
April 19, 2022
Sanofi (NASDAQ:SNY) will host a conference call at 08:30 AM ET on April 28, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
↗
April 18, 2022
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
41
42
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
